Literature DB >> 23721787

Cannabinoid-induced upregulation of serotonin 2A receptors in the hypothalamic paraventricular nucleus and anxiety-like behaviors in rats.

Jade M Franklin1, Matt Mathew, Gonzalo A Carrasco.   

Abstract

Recent behavioral reports suggest that repeated exposure to cannabis and synthetic cannabinoid agonists is linked with mental disorders associated with dysfunction of serotonin 2A (5-HT2A) receptor neurotransmission such as anxiety and depression. Here, we studied the effect of a nonselective cannabinoid agonist, CP55940, on the activity of 5-HT2A receptors in hypothalamic paraventricular nucleus (PVN). We detected that repeated exposure to CP55940 enhanced the prolactin and corticosterone neuroendocrine responses mediated by 5-HT2A receptors and increased the membrane-associated levels of 5-HT2A receptors in PVN. Importantly, we also detected increased anxiety-like behaviors in CP55940 treated rats compared to controls. The data presented here suggest that the mechanisms mediating the cannabinoid-induced upregulation of 5-HT2A receptors would be brain-region specific, as we were unable to detect a CP55940-induced upregulation of 5-HT2A mRNA. Our results might provide insight into the molecular mechanism by which repeated exposure to cannabinoids could be associated with the pathophysiology of neuropsychiatric disorders.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  (−) DOI; (−)-cis-3-[2-hydroxy-4-(1,1-dimethylheptyl)phenyl]-trans-4-(3-hydroxypropyl)cyclohexanol; 5-HT; 5-HT(2A); 5-HT(2A) receptor; 5-hydroxytryptamine; CP 55,940; ERK; G-proteins; Hypothalamus; Marijuana; PVN; Serotonin; [(−)-1-(2, 5-dimethoxy-4-iodophenyl)-2-aminopropane HCl]; extracellular kinase; hypothalamic paraventricular nucleus; serotonin 2A; Δ(9)-THC; Δ(9)-tetrahydrocannabinol

Mesh:

Substances:

Year:  2013        PMID: 23721787      PMCID: PMC3735609          DOI: 10.1016/j.neulet.2013.05.039

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  40 in total

1.  Evidence that 5-HT2A receptors in the hypothalamic paraventricular nucleus mediate neuroendocrine responses to (-)DOI.

Authors:  Yahong Zhang; Katerina J Damjanoska; Gonzalo A Carrasco; Bertalan Dudas; Deborah N D'Souza; Julie Tetzlaff; Francisca Garcia; Nicole R Sullivan Hanley; Kumar Scripathirathan; Brett R Petersen; Thackery S Gray; George Battaglia; Nancy A Muma; Louis D Van de Kar
Journal:  J Neurosci       Date:  2002-11-01       Impact factor: 6.167

2.  The PDZ-binding domain is essential for the dendritic targeting of 5-HT2A serotonin receptors in cortical pyramidal neurons in vitro.

Authors:  Z Xia; S J Hufeisen; J A Gray; B L Roth
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

3.  Cannabinoid CB1 receptor protein expression in the rat choroid plexus: a possible involvement of cannabinoids in the regulation of cerebrospinal fluid.

Authors:  John C Ashton; Ian Appleton; Cynthia L Darlington; Paul F Smith
Journal:  Neurosci Lett       Date:  2004-06-24       Impact factor: 3.046

Review 4.  Review of the validity and significance of cannabis withdrawal syndrome.

Authors:  Alan J Budney; John R Hughes; Brent A Moore; Ryan Vandrey
Journal:  Am J Psychiatry       Date:  2004-11       Impact factor: 18.112

5.  Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands.

Authors:  V M Showalter; D R Compton; B R Martin; M E Abood
Journal:  J Pharmacol Exp Ther       Date:  1996-09       Impact factor: 4.030

6.  Ultrastructural localization of the serotonin 2A receptor in dopaminergic neurons in the ventral tegmental area.

Authors:  M D Doherty; V M Pickel
Journal:  Brain Res       Date:  2000-05-12       Impact factor: 3.252

7.  5-HT2A receptors stimulate ACTH, corticosterone, oxytocin, renin, and prolactin release and activate hypothalamic CRF and oxytocin-expressing cells.

Authors:  L D Van de Kar; A Javed; Y Zhang; F Serres; D K Raap; T S Gray
Journal:  J Neurosci       Date:  2001-05-15       Impact factor: 6.167

Review 8.  Neuroendocrine pharmacology of stress.

Authors:  Gonzalo A Carrasco; Louis D Van de Kar
Journal:  Eur J Pharmacol       Date:  2003-02-28       Impact factor: 4.432

9.  Signaling pathway associated with stimulation of CB2 peripheral cannabinoid receptor. Involvement of both mitogen-activated protein kinase and induction of Krox-24 expression.

Authors:  M Bouaboula; C Poinot-Chazel; J Marchand; X Canat; B Bourrié; M Rinaldi-Carmona; B Calandra; G Le Fur; P Casellas
Journal:  Eur J Biochem       Date:  1996-05-01

10.  Cannabinoid 2 receptor- and beta Arrestin 2-dependent upregulation of serotonin 2A receptors.

Authors:  J M Franklin; T Vasiljevik; T E Prisinzano; G A Carrasco
Journal:  Eur Neuropsychopharmacol       Date:  2012-07-28       Impact factor: 4.600

View more
  14 in total

Review 1.  The K2/Spice phenomenon: emergence, identification, legislation and metabolic characterization of synthetic cannabinoids in herbal incense products.

Authors:  Lisa K Brents; Paul L Prather
Journal:  Drug Metab Rev       Date:  2013-09-24       Impact factor: 4.518

2.  Interrelationship of CB1R and OBR pathways in regulation of metabolic, neuroendocrine, and behavioral responses to food restriction and voluntary wheel running.

Authors:  Abdoulaye Diane; Donna F Vine; James C Russell; C Donald Heth; W David Pierce; Spencer D Proctor
Journal:  J Appl Physiol (1985)       Date:  2014-06-05

3.  Ultrastructural evidence for synaptic contacts between cortical noradrenergic afferents and endocannabinoid-synthesizing post-synaptic neurons.

Authors:  B A S Reyes; N A Heldt; K Mackie; E J Van Bockstaele
Journal:  Neuroscience       Date:  2015-07-08       Impact factor: 3.590

Review 4.  Drug discovery strategies that focus on the endocannabinoid signaling system in psychiatric disease.

Authors:  Ryan Wyrofsky; Paul McGonigle; Elisabeth J Van Bockstaele
Journal:  Expert Opin Drug Discov       Date:  2014-12-09       Impact factor: 6.098

5.  Cocaine potentiates multiple 5-HT2A receptor signaling pathways and is associated with decreased phosphorylation of 5-HT2A receptors in vivo.

Authors:  Jade M Franklin; Gonzalo A Carrasco
Journal:  J Mol Neurosci       Date:  2014-09-12       Impact factor: 3.444

Review 6.  Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications.

Authors:  Marisol S Castaneto; David A Gorelick; Nathalie A Desrosiers; Rebecca L Hartman; Sandrine Pirard; Marilyn A Huestis
Journal:  Drug Alcohol Depend       Date:  2014-08-18       Impact factor: 4.492

7.  Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors.

Authors:  Xavier Viñals; Estefanía Moreno; Laurence Lanfumey; Arnau Cordomí; Antoni Pastor; Rafael de La Torre; Paola Gasperini; Gemma Navarro; Lesley A Howell; Leonardo Pardo; Carmen Lluís; Enric I Canela; Peter J McCormick; Rafael Maldonado; Patricia Robledo
Journal:  PLoS Biol       Date:  2015-07-09       Impact factor: 8.029

8.  Unilateral angle-closure glaucoma with ciliochoroidal effusion after the consumption of cannabis: a case report.

Authors:  Rana Hanna; Beatrice Tiosano; Noora Dbayat; Dan Gaton
Journal:  Case Rep Ophthalmol       Date:  2014-12-10

Review 9.  Pro-psychotic effects of synthetic cannabinoids: interactions with central dopamine, serotonin, and glutamate systems.

Authors:  William E Fantegrossi; Catheryn D Wilson; Michael D Berquist
Journal:  Drug Metab Rev       Date:  2018-01-31       Impact factor: 4.518

Review 10.  High Times for Painful Blues: The Endocannabinoid System in Pain-Depression Comorbidity.

Authors:  Marie Fitzgibbon; David P Finn; Michelle Roche
Journal:  Int J Neuropsychopharmacol       Date:  2015-09-05       Impact factor: 5.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.